azacitidine has been researched along with Leukocytosis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akiyama, H; Hagino, T; Hidai, H; Motomura, S; Murai, Y; Saga, R; Sato, T | 1 |
| Brossart, P; Feldmann, G; von Lilienfeld-Toal, M | 1 |
| Parikh, SA; Tefferi, A | 1 |
| Dey, BR; Hasserjian, RP; Spitzer, TR | 1 |
1 review(s) available for azacitidine and Leukocytosis
| Article | Year |
|---|---|
Chronic myelomonocytic leukemia: 2013 update on diagnosis, risk stratification, and management.
Topics: Antimetabolites, Antineoplastic; Azacitidine; Decision Trees; Decitabine; Diagnosis, Differential; DNA Methylation; Humans; Leukemia, Myelomonocytic, Chronic; Leukocytosis; Monocytes; Mutation; Practice Guidelines as Topic; Prognosis | 2013 |
3 other study(ies) available for azacitidine and Leukocytosis
| Article | Year |
|---|---|
Myeloid leukemoid reaction after initial azacitidine therapy for chronic myelomonocytic leukemia.
Topics: Aged, 80 and over; Azacitidine; Humans; Leukemia, Myelomonocytic, Chronic; Leukemia, Myelomonocytic, Juvenile; Leukemoid Reaction; Leukocytosis; Male | 2022 |
Transient and fully reversible leukocytosis in a myelodysplastic syndrome patient upon initiation of azacitidine treatment.
Topics: Aged, 80 and over; Antimetabolites, Antineoplastic; Azacitidine; Humans; Leukocytosis; Male; Myelodysplastic Syndromes; Treatment Outcome | 2013 |
Case records of the Massachusetts General Hospital. Case 28-2009. A 68-year-old man with fatigue, cough, and peripheral-blood monocytosis.
Topics: Aged; Antimetabolites, Antineoplastic; Azacitidine; Bone Marrow; Bone Marrow Examination; Combined Modality Therapy; Cough; Decitabine; Diagnosis, Differential; Fatigue; Humans; Leukemia, Myeloid, Acute; Leukocytosis; Male; Monocytes; Stem Cell Transplantation | 2009 |